There are a number of on-going clinical studies on BioMin® containing toothpaste using commercially produced materials. The first to be published is;
|Clinical Studies (Abstracts)|
Gautam V and Kumar Halwai:
IJSR - INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH Vol6. Issue-2. February 2017 ISSN no2277-8179 IF:3.508
The patients' DH scores for tactile, thermal, and evaporative stimuli were recorded on a visual analog scale at baseline, 2 weeks, 1 month, and 2 months.
A randomised clinical trial on the efficacy of 5% Fluorocalcium Phosphosilicate containing novel bioactive glass toothpaste
J Oral Rehabil 2019 Jun 24. Epub 2019 Jun 24:
Background and aim:
The results showed symptoms of DH were reduced in all three groups. However, Group A showed a better reduction of DH than the other two groups.
The toothpaste containing 5% Fluoro Calcium Phosphosilicate was reported to be more efficacious than the other two toothpastes in managing DH.
This novel development opens up a unique opportunity in the prevention and management of DH and may also be beneficial in preventing acid erosion of the tooth surface and in the maintenance of oral hygiene by reducing the effects of plaque accumulation and gingival inflammation. This article is protected by copyright. All rights reserved.